Investor Videos

Corporate Videos

Fusion Antibodies reports second-half rebound as new commercial strategy pays off

Adrian Kinkaid discusses the Company’s involvement in antibodies which are widely used in leading therapeutics, and a more general update on the business

Fusion Antibodies present their 'world class, groundbreaking expertise and services'

Investor Presentation

Fusion Antibodies CEO sees 'enormous value' in discovery platform as it expands to include COVID-19

Fusion Antibodies - Placing to Raise £3m

Paul Kerr, CEO of Fusion Antibodies, talks about the company's recent placing to raise £3m along with an update around Covid-19 and plans for the rest of the year.

Market Open